Akeso begins patient enrolment in phase I trial of AK138 D1 for the treatment of advanced malignancies in Australia: Hong Kong Saturday, March 1, 2025, 12:00 Hrs [IST] Akeso, Inc.

CANFIELD, Ohio (MyValleyTributes) – Domenico Fabiilli, 99, passed away peacefully on Sunday February 23, 2025 at The Inn at Old Saybrook in Columbiana. Domenico was born in 1925 in Pacentro, Abruzzo, ...

Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by anti-corruption authorities. | Eisai plans to lay off 121 employees in the U.

Goldman Sachs analyst Salveen Richter initiated coverage of Summit Therapeutics (SMMT) with a Buy rating and $42 price target a Summit’s lead ...

Akeso, Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment ...

Heralding the beginning of a new era, Kempinski Hotels have signed a landmark agreement to manage the Nymphenburg Palace ...

Akeso, Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in Australia. AK138D1, a self-developed and ...

A little-known Chinese company has made a drug that beats the world's biggest-selling medicine, said a CNN report on ...

A case study on how one of the leading pharma companies in the oncology space approached DelveInsight with a pressing need for conference coverage to monitor the activities and data readouts of ...

NEW MIDDLETOWN, Ohio (MyValleyTributes) – On Friday, February 22, 2025, Thomas Frederick Geidner, age 82, passed away. He was ...

China’s DeepSeek shocked the world by delivering unexpected innovation at an unbelievable price in January. But this ...